Literature DB >> 19037586

High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker.

Hem Chandra Jha1, Jagdish Prasad, Aruna Mittal.   

Abstract

Atherosclerosis is increasingly recognized as a chronic inflammatory disease. A variety of infectious agents (Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus [CMV]) and inflammatory marker such as high-sensitivity C-reactive protein (hs-CRP) have been found to be associated with atherosclerosis and its consequences. There is a need to know about the type and burden of infection in coronary artery disease (CAD) patients and the level of hs-CRP in India as there is growing evidence that a variety of pathogens are participating in the development and/or acceleration of at least pre-existing atherosclerosis. In addition, there is a need to find the association between these pathogens and conventional risk factors among CAD patients in India, to possibly identify a prognostic marker. In this study 192 patients with incident or prevalent CAD attending the Cardiology Outpatient Department of Safdarjung Hospital, New Delhi, India, were enrolled. In addition, 192 age-and sex-matched controls were also included. Cases and controls differ significantly in seropositivity to C. pneumoniae immunoglobulin IgA (154 vs 76) and IgG (71 vs 48) (P < 0.001, P < 0.015), H. pylori IgA (98 vs 57) and IgG (77 vs 43) (P < 0.001, P < 0.001), CMV IgG (62 vs 38) (P = 0.01) and with hs-CRP (114 vs 60) (P < 0.001), respectively. The level of hs-CRP was higher in CAD patients with IgA seropositivity of C. pneumoniae and H. pylori (5.18 and.65 mg/l) than the IgG of these bacteria (3.73 and 3.36 mg/l), respectively. These findings support an association between specific infectious agents, namely, C. pneumoniae, H. pylori, CMV, and hs-CRP in CAD patients. Association of hs-CRP with IgA specific for C. pneumoniae and H. pylori suggests the role of chronic infection in the development of CAD and may be used as a marker to target the population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19037586     DOI: 10.1007/s00380-008-1062-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  33 in total

Review 1.  Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.

Authors:  John P Higgins
Journal:  Mayo Clin Proc       Date:  2003-03       Impact factor: 7.616

2.  Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study.

Authors:  S Kiechl; J Willeit; G Rungger; G Egger; F Oberhollenzer; E Bonora
Journal:  Stroke       Date:  1998-05       Impact factor: 7.914

3.  Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus.

Authors:  C G Solomon; F B Hu; M J Stampfer; G A Colditz; F E Speizer; E B Rimm; W C Willett; J E Manson
Journal:  Circulation       Date:  2000-08-01       Impact factor: 29.690

4.  Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.

Authors:  J Sheehan; P M Kearney; S O Sullivan; C Mongan; E Kelly; I J Perry
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

5.  Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not.

Authors:  J M Ossewaarde; E J Feskens; A De Vries; C E Vallinga; D Kromhout
Journal:  Epidemiol Infect       Date:  1998-02       Impact factor: 2.451

6.  Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque.

Authors:  R LaBiche; D Koziol; T C Quinn; C Gaydos; S Azhar; G Ketron; S Sood; T J DeGraba
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

Review 7.  Chlamydia pneumoniae and cardiovascular disease.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

Review 8.  Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation.

Authors:  Thomas J DeGraba
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

9.  The association of prior cytomegalovirus infection with neovascular age-related macular degeneration.

Authors:  Daniel M Miller; Diego G Espinosa-Heidmann; Jessica Legra; Sander R Dubovy; Ivan J Sũner; Daniel D Sedmak; Richard D Dix; Scott W Cousins
Journal:  Am J Ophthalmol       Date:  2004-09       Impact factor: 5.258

10.  C-reactive protein elevation and disease activity in patients with coronary artery disease.

Authors:  Ramón Arroyo-Espliguero; Pablo Avanzas; Juan Cosín-Sales; Guillermo Aldama; Carmine Pizzi; Juan Carlos Kaski
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983

View more
  12 in total

1.  Cytomegalovirus infection and coronary heart disease risk: a meta-analysis.

Authors:  Ya-Nan Ji; Li An; Ping Zhan; Xiao-Hu Chen
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 2.  Helicobacter pylori: Does it add to risk of coronary artery disease.

Authors:  Vishal Sharma; Amitesh Aggarwal
Journal:  World J Cardiol       Date:  2015-01-26

3.  Pathogen burden, cytomegalovirus infection and inflammatory markers in the risk of premature coronary artery disease in individuals of Indian origin.

Authors:  Lakshmi A Mundkur; Veena S Rao; Sridhar Hebbagudi; Jayashree Shanker; Hemapriya Shivanandan; Radhika K Nagaraj; Vijay V Kakkar
Journal:  Exp Clin Cardiol       Date:  2012

4.  Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction.

Authors:  Masayuki Ueeda; Takenori Doumei; Yoichi Takaya; Nobuhiko Ohnishi; Atsushi Takaishi; Satoshi Hirohata; Toru Miyoshi; Ryoko Shinohata; Shinichi Usui; Shozo Kusachi
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

5.  A link between platelet to lymphocyte ratio and Helicobacter pylori infection.

Authors:  Raymond Farah; Hamza Hamza; Rola Khamisy-Farah
Journal:  J Clin Lab Anal       Date:  2017-04-04       Impact factor: 2.352

6.  Association of neutrophil to lymphocyte ratio with presence and severity of gastritis due to Helicobacter pylori infection.

Authors:  Raymond Farah; Rola Khamisy-Farah
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

7.  Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial.

Authors:  Ali Kachuei; Masoud Amini; Vahid Sebghatollahi; Awat Feizi; Pooria Hamedani; Bijan Iraj
Journal:  J Res Med Sci       Date:  2016-02-23       Impact factor: 1.852

8.  Potential Anti-Inflammatory Treatment of Ischemic Heart Disease.

Authors:  Enisa Hodzic
Journal:  Med Arch       Date:  2018-04

9.  Association of plasma circulatory markers, Chlamydia pneumoniae, and high sensitive C-reactive protein in coronary artery disease patients of India.

Authors:  Hem Chandra Jha; Pragya Srivastava; Rakesh Sarkar; Jagdish Prasad; Aruna Singh Mittal
Journal:  Mediators Inflamm       Date:  2009-04-05       Impact factor: 4.711

Review 10.  ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.

Authors:  Sofia D Viana; Sara Nunes; Flávio Reis
Journal:  Ageing Res Rev       Date:  2020-07-16       Impact factor: 11.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.